{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T07:04:09Z","timestamp":1776582249545,"version":"3.51.2"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.semradonc.2022.01.004","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T06:47:00Z","timestamp":1654584420000},"page":"221-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Regional Nodal Management in the Setting of Up-Front Surgery"],"prefix":"10.1016","volume":"32","author":[{"given":"Lior Z.","family":"Braunstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2022.01.004_bib0001","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa020128","article-title":"Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0002","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0003","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/SLA.0b013e3181c0e92a","article-title":"Sentinel lymph node biopsy in breast cancer: Ten-year results of a randomized controlled study","volume":"251","author":"Veronesi","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0004","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0005","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): A randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0006","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0007","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: The optimal treatment of the Axilla - surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"S\u00e1volt","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0008","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1377\/hlthaff.2015.1490","article-title":"Contrary to conventional wisdom, physicians abandoned a breast cancer treatment after a trial concluded it was ineffective","volume":"35","author":"Howard","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0009","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1245\/s10434-018-6384-y","article-title":"Risk of regional recurrence after negative repeat sentinel lymph node biopsy in patients with ipsilateral breast tumor recurrence","volume":"25","author":"Poodt","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/SLA.0000000000002354","article-title":"Axillary dissection and nodal irradiation can be avoided for most node-positive Z0011-eligible breast cancers: a prospective validation study of 793 patients","volume":"266","author":"Morrow","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0011","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1245\/s10434-019-08104-1","article-title":"Microscopic extracapsular extension in sentinel lymph nodes does not mandate axillary dissection in Z0011-eligible patients","volume":"27","author":"Barrio","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0012","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jamcollsurg.2015.11.013","article-title":"Is preoperative axillary imaging beneficial in identifying clinically node-negative patients requiring axillary lymph node dissection?","volume":"222","author":"Pilewskie","year":"2016","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0013","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1245\/s10434-015-4944-y","article-title":"Does a positive axillary lymph node needle biopsy result predict the need for an axillary lymph node dissection in clinically node-negative breast cancer patients in the ACOSOG Z0011 era?","volume":"23","author":"Pilewskie","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0014","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal mammary and medial supraclavicular irradiation in breast cancer","volume":"373","author":"Poortmans","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0016","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.clon.2015.07.005","article-title":"POSNOC: A randomised trial looking at axillary treatment in women with one or two sentinel nodes with macrometastases","volume":"27","author":"Goyal","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0017","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12885-017-3361-y","article-title":"Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial","volume":"17","author":"de Boniface","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0018","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","article-title":"Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: Findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial","volume":"260","author":"Boughey","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0019","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1245\/s10434-020-08650-z","article-title":"Selecting node-positive patients for axillary downstaging with neoadjuvant chemotherapy","volume":"27","author":"Montagna","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0020","series-title":"Presented at the 43rd Annual San Antonio Breast Cancer Symposium","author":"Kalinsky","year":"2020"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0021","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","article-title":"Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from national surgical adjuvant breast and bowel project B-18","volume":"15","author":"Fisher","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0022","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1245\/s10434-020-09228-5","article-title":"Assessing the burden of nodal disease for breast cancer patients with clinically positive nodes: Hope for more limited axillary surgery","volume":"28","author":"Angarita","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0023","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1245\/s10434-021-09943-7","article-title":"Palpable adenopathy does not indicate high-volume axillary nodal disease in hormone receptor-positive breast cancer","volume":"28","author":"Crown","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0024","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1245\/s10434-017-6016-y","article-title":"The optimal treatment plan to avoid axillary lymph node dissection in early-stage breast cancer patients differs by surgical strategy and tumor subtype","volume":"24","author":"Pilewskie","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0025","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM199710023371401","article-title":"Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial","volume":"337","author":"Overgaard","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0026","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(98)09201-0","article-title":"Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial","volume":"353","author":"Overgaard","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0027","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0028","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaccao.2021.07.008","article-title":"Coronary artery disease in young women after radiation therapy for breast cancer: the WECARE study","volume":"3","author":"Carlson","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0029","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijrobp.2020.12.053","article-title":"Risk of cardiac disease in patients with breast cancer: Impact of patient-specific factors and individual heart dose from three-dimensional radiation therapy planning","volume":"110","author":"Chung","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0031","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.radonc.2021.01.010","article-title":"Risk of coronary artery disease after adjuvant radiotherapy in 29,662 early breast cancer patients: A population-based Danish Breast Cancer Group study","volume":"157","author":"Milo","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0032","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijrobp.2013.11.232","article-title":"The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: A prospective cohort study","volume":"88","author":"Warren","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0033","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1245\/s10434-014-3483-2","article-title":"Implant breast reconstruction and radiation: a multicenter analysis of long-term health-related quality of life and satisfaction","volume":"21","author":"Albornoz","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0034","doi-asserted-by":"crossref","first-page":"60s","DOI":"10.1097\/PRS.0000000000003943","article-title":"Breast reconstruction and radiation therapy: An update","volume":"140","author":"Nelson","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0035","unstructured":"Hypofractionated Radiation Therapy after mastectomy in preventing recurrence in patients with stage IIa-IIIa breast cancer. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03414970. Accessed November 14, 2021."},{"key":"10.1016\/j.semradonc.2022.01.004_bib0036","unstructured":"Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03422003. Accessed November 14, 2021."},{"key":"10.1016\/j.semradonc.2022.01.004_bib0037","unstructured":"Pragmatic Randomized Trial of proton vs. photon therapy for patients with non-metastatic breast cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02603341. Accessed November 14, 2021."},{"key":"10.1016\/j.semradonc.2022.01.004_bib0038","unstructured":"Regional Radiotherapy in Biomarker Low-risk node positive and T3N0 Breast Cancer (TAILOR RT). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03488693. Accessed November 14, 2021."},{"key":"10.1016\/j.semradonc.2022.01.004_bib0039","unstructured":"POSNOC - A Trial looking at axillary treatment in early breast cancer (POSNOC). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02401685. Accessed November 14, 2021."},{"key":"10.1016\/j.semradonc.2022.01.004_bib0040","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1200\/JCO.2011.40.8369","article-title":"Predictors of locoregional recurrence after neoadjuvant chemotherapy: Results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27","volume":"30","author":"Mamounas","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0041","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JCO.2002.20.1.17","article-title":"Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation","volume":"20","author":"Buchholz","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0042","unstructured":"Comparison of Axillary Lymph Node Dissection with axillary radiation for patients with node-positive breast cancer treated with chemotherapy. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01901094. Accessed November 14, 2021."},{"key":"10.1016\/j.semradonc.2022.01.004_bib0043","unstructured":"Standard or Comprehensive Radiation Therapy in treating patients with early-stage breast cancer previously treated with chemotherapy and surgery. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01872975. Accessed November 14, 2021."},{"key":"10.1016\/j.semradonc.2022.01.004_bib0044","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","article-title":"Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND)","volume":"21","author":"Gentilini","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0042-122853","article-title":"Restricted axillary staging in clinically and sonographically node-negative early invasive breast cancer (c\/iT1-2) in the context of breast conserving therapy: First results following commencement of the intergroup-sentinel-mamma (INSEMA) trial","volume":"77","author":"Reimer","year":"2017","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0046","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0047","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: Long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0048","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.2005.01.5784","article-title":"Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: First results of International Breast Cancer Study Group Trial 10-93","volume":"24","author":"Rudenstam","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.01.004_bib0049","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1245\/s10434-016-5330-0","article-title":"Impact of body mass index on clinical axillary nodal assessment in breast cancer patients","volume":"23","author":"McCartan","year":"2016","journal-title":"Ann Surg Oncol"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429622000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429622000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:53:18Z","timestamp":1760950398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429622000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1053429622000042"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2022.01.004","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional Nodal Management in the Setting of Up-Front Surgery","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2022.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}